Government Briefs

If At First You Don’t Succeed The four states—Idaho, Louisiana, Mississippi, and South Dakota—that have just been awarded three-year, $1.8 million grants from the National Science Foundation know what it’s like to try, try again. Each of them has lost out in previous bids to receive funds under a 10-year-old program that is meant to help states at the bottom of the federal research pile do better by improving the quality of their science. “Louisiana is going thro

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The four states—Idaho, Louisiana, Mississippi, and South Dakota—that have just been awarded three-year, $1.8 million grants from the National Science Foundation know what it’s like to try, try again. Each of them has lost out in previous bids to receive funds under a 10-year-old program that is meant to help states at the bottom of the federal research pile do better by improving the quality of their science. “Louisiana is going through so many problems these days that it’s nice to have something good happen to us,” says Gene D’Amour, vice. president for research at Tulane University and chairman of the state’s EPSCoR (Experimental Program to Stimulate Competitive Research) committee. In Louisiana’s case, the NSF grant is icing on a cake produced by the state’s $20 million annual pledge to provide equipment, staff support, and research funds to scientists throughout the state. In addition to matching funds from state coffers, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies